140 related articles for article (PubMed ID: 27720890)
21. CD44 expression in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study.
Davidson B; Goldberg I; Gotlieb WH; Ben-Baruch G; Kopolovic J
Eur J Gynaecol Oncol; 1998; 19(1):46-9. PubMed ID: 9476059
[TBL] [Abstract][Full Text] [Related]
22. Expression of the cell cycle regulator p27(Kip1) in normal squamous epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix. Immunohistochemistry and functional aspects of p27(Kip1).
Shiozawa T; Shiohara S; Kanai M; Konishi I; Fujii S; Nikaido T
Cancer; 2001 Dec; 92(12):3005-11. PubMed ID: 11753978
[TBL] [Abstract][Full Text] [Related]
23. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
Nagai N; Oshita T; Murakami J; Ohama K
Oncol Rep; 1999; 6(2):325-8. PubMed ID: 10022998
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma.
Rufforny I; Wilkinson EJ; Liu C; Zhu H; Buteral M; Massoll NA
J Low Genit Tract Dis; 2005 Apr; 9(2):108-13. PubMed ID: 15870532
[TBL] [Abstract][Full Text] [Related]
25. Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas.
Oktay MH; Oktay K; Hamele-Bena D; Buyuk A; Koss LG
Hum Pathol; 2003 Mar; 34(3):240-5. PubMed ID: 12673558
[TBL] [Abstract][Full Text] [Related]
26. PRb2/p130, p107 and p53 expression in precancerous lesions and squamous cell carcinoma of the uterine cervix.
Cenci M; Pisani T; French D; Alderisio M; Vecchione A
Anticancer Res; 2005; 25(3B):2187-92. PubMed ID: 16158962
[TBL] [Abstract][Full Text] [Related]
27. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.
Hopman AH; Kamps MA; Smedts F; Speel EJ; Herrington CS; Ramaekers FC
Int J Cancer; 2005 Jun; 115(3):419-28. PubMed ID: 15688369
[TBL] [Abstract][Full Text] [Related]
28. Aminopeptidase A expression in cervical neoplasia and its relationship to neoplastic transformation and progression.
Fujimura H; Ino K; Nagasaka T; Nakashima N; Nakazato H; Kikkawa F; Mizutani S
Oncology; 2000 May; 58(4):342-52. PubMed ID: 10838501
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia.
Ishikawa M; Fujii T; Saito M; Nindl I; Ono A; Kubushiro K; Tsukazaki K; Mukai M; Nozawa S
Int J Gynecol Cancer; 2006; 16(1):347-53. PubMed ID: 16445657
[TBL] [Abstract][Full Text] [Related]
30. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis.
Qiao X; Bhuiya TA; Spitzer M
J Low Genit Tract Dis; 2005 Apr; 9(2):100-7. PubMed ID: 15870531
[TBL] [Abstract][Full Text] [Related]
31. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation--an immunohistochemical study.
Brummer O; Böhmer G; Hollwitz B; Flemming P; Petry KU; Kühnle H
Gynecol Oncol; 2002 Feb; 84(2):222-7. PubMed ID: 11812078
[TBL] [Abstract][Full Text] [Related]
32. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia.
Kalof AN; Evans MF; Simmons-Arnold L; Beatty BG; Cooper K
Am J Surg Pathol; 2005 May; 29(5):674-9. PubMed ID: 15832093
[TBL] [Abstract][Full Text] [Related]
33. MIB 1 immunostaining in cervical intraepithelial neoplasia: prognostic significance in mild and moderate lesions.
Garzetti GG; Ciavattini A; De Nictolis M; Lucarini G; Goteri G; Romanini C; Biagini G
Gynecol Obstet Invest; 1996; 42(4):261-6. PubMed ID: 8979100
[TBL] [Abstract][Full Text] [Related]
34. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer.
Wang JL; Zheng BY; Li XD; Angström T; Lindström MS; Wallin KL
Clin Cancer Res; 2004 Apr; 10(7):2407-14. PubMed ID: 15073118
[TBL] [Abstract][Full Text] [Related]
35. Early acquisition of gelatinolytic activity in carcinogenesis of the uterine cervix.
Minami R; Tsunoda H; Iijima T; Yoshikawa H; Nemori R; Noguchi M
Mod Pathol; 2003 Nov; 16(11):1164-70. PubMed ID: 14614057
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Benedetto A; Paba P; Costa S; Bonifacio D; Di Bonito P; Accardi L; Favalli C; Syrjänen K;
J Clin Pathol; 2006 Jan; 59(1):40-7. PubMed ID: 16394279
[TBL] [Abstract][Full Text] [Related]
37. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
[TBL] [Abstract][Full Text] [Related]
38. Changes in the topological expression of markers of differentiation and apoptosis in defined stages of human cervical dysplasia and carcinoma.
Zanotti S; Fisseler-Eckhoff A; Mannherz HG
Gynecol Oncol; 2003 Jun; 89(3):376-84. PubMed ID: 12798698
[TBL] [Abstract][Full Text] [Related]
39. Invasive squamous cell carcinoma and cervical intraepithelial neoplasia III of uterine cervix. Morphologic differences other than stromal invasion.
Leung KM; Chan WY; Hui PK
Am J Clin Pathol; 1994 Apr; 101(4):508-13. PubMed ID: 7512787
[TBL] [Abstract][Full Text] [Related]
40. Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix.
Chil A; Sikorski M; Bobek M; Jakiel G; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1146-52. PubMed ID: 14616262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]